Ekso Bionics (EKSO)
Wearable exoskeletons for rehabilitation, personal mobility, and industrial arm support.
Something off on this page? Send us feedback.
Ekso Bionics provides wearable exoskeletons for neurorehabilitation, personal mobility after spinal cord injury, and industrial arm support. It is pursuing a business combination with Applied Digital Cloud that would rename the company ChronoScale if completed.
Ekso Bionics Holdings is a San Rafael, California company founded in 2005 that designs, develops and markets exoskeleton and complementary rehabilitation products. Its healthcare portfolio includes EksoNR for clinician-led gait training in spinal cord injury, acquired brain injury including stroke and traumatic brain injury, and multiple sclerosis; Ekso Indego Therapy for rehabilitation and wellness applications; and Ekso Indego Personal for home and community ambulation by eligible spinal cord injury users.
It also provides EksoCare service, support and training, distributes products through direct and partner channels, and offers EVO for upper-body industrial ergonomics. Recent filings say most sales still come from Enterprise Health clinical customers, while Personal Health depends on reimbursement partners and documentation. Ekso has agreed to combine with Applied Digital Cloud; closing depends on required approvals, financing, Nasdaq listing review and other conditions, after which the company expects to rename itself ChronoScale.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Mar 31, 2026Cash & short-term investments $4.0M · Total debt $4.3M · Total assets $19.7M · Shareholders' equity $5.7M
- Revenue
- $2.1M
- Operating income
- −$5.6M
- Net income
- −$6.9M
No dividends on record.
| Institutions | 0.08% | 2.9K shares | |
|---|---|---|---|
| 1 holder · as of Jun 30, 2026 | |||
| Insiders | 35.29% | 1.26M shares | |
| 9 holders · as of Mar 20, 2026 | |||
| Strategic holders | 8.13% | 289.9K shares | |
| 1 holder · as of Aug 14, 2025 | |||
| Other | 56.50% | 2.01M shares | |
| remainder | |||
3.56M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (3.56M in the company's Sep 22, 2026 report, 2.43M elsewhere); stakes use the report.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Daniel Asher1Insider10 percent owner | 22.35% | 677,723 | filed Feb 20, 2026 |
Armistice Capital, LLCStrategic | 8.13% | 289,876 | filed Aug 14, 2025 |
Kosow KeithInsider | 5.89% | 210,000 | filed Mar 19, 2026 |
Scott G. DavisInsiderdirector, officer: CEO | 2.22% | 79,150 | filed Nov 12, 2025 |
Corinna LathanInsiderdirector | 0.87% | 30,827 | filed May 19, 2025 |
- Daniel Asher's transaction reports restate only vehicles that traded; the 2026 ownership statement (677.7K) plus the 118.8K net shares acquired since is used instead.
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Mar 16, 2026 | Jerome Wong | officer: Chief Financial Officer | +1,308 | $11.85 |
| Mar 16, 2026 | Jason C. Jones | officer: Chief Operating Officer | +1,308 | $11.85 |
| Feb 19, 2026 | Daniel Asher | 10 percent owner | +16,740 | $12.11 |
| Feb 6, 2026 | Daniel Asher | 10 percent owner | +194 | $9.86 |
| Feb 9, 2026 | Daniel Asher | 10 percent owner | +4,800 | $9.96 |
Not reported.